StockTipsArenaBeta

Pfizer Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹3,688.9-65.80 (-1.75%)

Avg 1-year target

All 6 long-term calls are BUY

₹5,774.556.5% above today's price

Pfizer's average 1-year share price target is ₹5,774.5, the average of 2 advisors' latest targets. Targets range from ₹5,734 to ₹5,815.

Latest: ICICI Securities ₹5,815 · 29 Jul 2026

7
7 BUY · 0 SELL, all horizons
2
with an active 1Y target
N/A
6 of 10 closed calls needed
13
all horizons, open and closed
Watch PFIZER for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Pfizer target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (13)

BUYTarget₹5,815
ISbyICICI Securities+57.6% to target
1 Year* · 9 mo left · 29 Jul 2026 · entry ₹4,755.1 · via Institutional / Brokerage ResearchP&L -22.4%
BUYTarget₹6,000
ISbyICICI Securities+62.7% to target
1 Year* · 9 mo left · 10 Jul 2026 · entry ₹4,731.4 · via Moneycontrol Broker ResearchP&L -22.0%
BUYTarget₹5,734
SSbySystematix Shares & Stock+55.4% to target
1 Year* · 9 mo left · 7 Jul 2026 · entry ₹4,578 · via Economic Times Stock Recos OverviewP&L -19.4%
BUYTarget₹5,750
ISbyICICI Securities+55.9% to target
1 Year* · 7 mo left · 13 May 2026 · entry ₹4,613.5 · via Institutional / Brokerage ResearchP&L -20.0%
BUYTarget₹6,030
ISbyICICI Securities+63.5% to target
1 Year* · 4 mo left · 10 Feb 2026 · entry ₹4,960.8 · via Institutional / Brokerage ResearchP&L -25.6%
BUYTarget₹6,100
ISbyICICI Securities+65.4% to target
1 Year* · 3 wk left · 14 Nov 2025 · entry ₹5,074 · via Institutional / Brokerage ResearchP&L -27.3%
BUYTarget₹5,150
SJbySandeep Jain, Tradeswift+39.6% to target
1–3 Months · 8d left · 31 Jul 2026 · entry ₹4,838.2 · via Zee Business (Live)P&L -23.8%
BUYTarget₹5,200
SCbyShrikant Chouhan, Kotak SecuritiesStop-loss hit
1–2 Weeks* · 19 Aug 2026 · entry ₹4,961.3 · via ET Nowexit ₹4,800
BUYTarget₹5,050
SRbySahi ResearchStop-loss hit
1–2 Weeks* · 19 Aug 2026 · entry ₹4,870 · via Sahi Research Telegramexit ₹4,745
BUYTarget₹6,000
VRbyVinay Rajani, HDFC SecuritiesExpired
1–2 Weeks* · 13 Aug 2026 · entry ₹5,003.2 · via NDTV Profit (Live)exit ₹4,814
BUYTarget₹6,000
OKbyOsho Krishan, Angel OneExpired
1–2 Weeks* · 13 Aug 2026 · entry ₹4,997 · via NDTV Profit (Live)exit ₹4,814
BUYTarget₹5,050
AJbyAastha Jain, Hem SecuritiesExpired
BTST · 3 Aug 2026 · entry ₹4,919.6 · via Zee Business (Live)exit ₹4,853.6
BUYTarget₹5,015
AJbyAastha Jain, Hem SecuritiesExpired
Intraday* · 20 Aug 2026 · entry ₹4,961.3 · via Zee Business (Live)exit ₹4,924.7

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks